Literature DB >> 31683294

Type 2 Diabetes.

Sandeep Vijan1.   

Abstract

Type 2 diabetes is a prevalent illness that causes major vascular, renal, and neurologic complications. Prevention and treatment of diabetes and its complications are of paramount importance. Many new treatments have emerged over the past 5-10 years. Recent evidence shows that newer treatments may substantially reduce risk for cardiac and renal disease, suggesting that it may be necessary to change existing treatment paradigms. This review summarizes the evidence supporting diabetes prevention and treatment, focusing on aspects that are commonly in the purview of primary care physicians.

Entities:  

Mesh:

Year:  2019        PMID: 31683294     DOI: 10.7326/AITC201911050

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

1.  A prediction nomogram for the 3-year risk of incident diabetes among Chinese adults.

Authors:  Yang Wu; Haofei Hu; Jinlin Cai; Runtian Chen; Xin Zuo; Heng Cheng; Dewen Yan
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

2.  Comparative Cardio-Renal Outcomes of Type 2 Diabetes Patients Administered Glucagon-Like Peptide-1 Receptor Agonists: A Network Meta-Analysis.

Authors:  Chuanjun Zhuo; Chongguang Lin; Chunhua Zhou; Xiangyang Gao; Hailin Shao; Tao Fang; Hongjun Tian; Li Ding; Ming Liu
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

3.  Cut points and contexts.

Authors:  Evan L Busch
Journal:  Cancer       Date:  2021-08-23       Impact factor: 6.921

Review 4.  Roles and mechanisms of exosomal non-coding RNAs in human health and diseases.

Authors:  Chen Li; Yu-Qing Ni; Hui Xu; Qun-Yan Xiang; Yan Zhao; Jun-Kun Zhan; Jie-Yu He; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2021-11-10

5.  Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care.

Authors:  Alex R Montero; David Toro-Tobon; Kelly Gann; Carine M Nassar; Gretchen A Youssef; Michelle F Magee
Journal:  BMC Endocr Disord       Date:  2021-11-10       Impact factor: 2.763

6.  The Effect of SOCS2 Polymorphisms on Type 2 Diabetes Mellitus Susceptibility and Diabetic Complications in the Chinese Han Population.

Authors:  Juan Pan; Rui Tong; Qing Deng; Yanni Tian; Ning Wang; Yanqi Peng; Sijia Fei; Wei Zhang; Jiaqi Cui; Chaoying Guo; Juanchuan Yao; Cui Wei; Jing Xu
Journal:  Pharmgenomics Pers Med       Date:  2022-01-29

7.  Sodium-Glucose Co-Transporter 2 Inhibitors Use Improves the Satisfaction With Anti-diabetic Agent Treatment: A Questionnaire-based Propensity Score-matched Study.

Authors:  Fang-Hong Shi; Jiang Yue; Yi-Hong Jiang; Ming-Lan Yang; Zhi-Chun Gu; Jing Ma; Hao Li
Journal:  Front Pharmacol       Date:  2022-02-01       Impact factor: 5.810

8.  α-Lipoic Acid Strengthens the Antioxidant Barrier and Reduces Oxidative, Nitrosative, and Glycative Damage, as well as Inhibits Inflammation and Apoptosis in the Hypothalamus but Not in the Cerebral Cortex of Insulin-Resistant Rats.

Authors:  Mateusz Maciejczyk; Ewa Żebrowska; Miłosz Nesterowicz; Małgorzata Żendzian-Piotrowska; Anna Zalewska
Journal:  Oxid Med Cell Longev       Date:  2022-03-29       Impact factor: 6.543

9.  Low TSH Levels Within Euthyroid Range Could Play a Negative Role on Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes.

Authors:  Congying Liu; Junhong Pan; Song Wen; Thiquynhnga Nguyen; Dongxiang Xu; Chaoxun Wang; Xinlu Yuan; Zhongqiu Wen; Ligang Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-24       Impact factor: 3.168

Review 10.  The Role of Semaphorins in Metabolic Disorders.

Authors:  Qiongyu Lu; Li Zhu
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.